ID

34544

Description

3D Echo Evaluation of the Ventricles in Sclero Associated Severe PAH; ODM derived from: https://clinicaltrials.gov/show/NCT02207868

Lien

https://clinicaltrials.gov/show/NCT02207868

Mots-clés

  1. 19/01/2019 19/01/2019 -
  2. 22/05/2019 22/05/2019 -
Détendeur de droits

see on clinicaltrials.gov

Téléchargé le

19 janvier 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Pulmonary Arterial Hypertension NCT02207868

Eligibility Pulmonary Arterial Hypertension NCT02207868

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
age >17
Description

ID.1

Type de données

boolean

pulmonary arterial hypertension (pah) associated with who group 1 who start a parenteral prostanoid-therapy
Description

ID.2

Type de données

boolean

written informed consent
Description

ID.3

Type de données

boolean

prostanoid naive
Description

ID.4

Type de données

boolean

no change of the pah specific therapy within 3 weeks of the recruitment to the study
Description

ID.5

Type de données

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnancy and lactation period
Description

ID.6

Type de données

boolean

women of child bearing potential who do not use an effective and secure method for birth control
Description

ID.7

Type de données

boolean

severe chronic kidney insufficiency (glomerular filtration rate <30), which will remain for more than 3 months
Description

ID.8

Type de données

boolean

liver-insufficiency child c
Description

ID.9

Type de données

boolean

life expectancy shorter than the course of the study (for example because of malignant disease
Description

ID.10

Type de données

boolean

Similar models

Eligibility Pulmonary Arterial Hypertension NCT02207868

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
age >17
boolean
ID.2
Item
pulmonary arterial hypertension (pah) associated with who group 1 who start a parenteral prostanoid-therapy
boolean
ID.3
Item
written informed consent
boolean
ID.4
Item
prostanoid naive
boolean
ID.5
Item
no change of the pah specific therapy within 3 weeks of the recruitment to the study
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
pregnancy and lactation period
boolean
ID.7
Item
women of child bearing potential who do not use an effective and secure method for birth control
boolean
ID.8
Item
severe chronic kidney insufficiency (glomerular filtration rate <30), which will remain for more than 3 months
boolean
ID.9
Item
liver-insufficiency child c
boolean
ID.10
Item
life expectancy shorter than the course of the study (for example because of malignant disease
boolean

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial